Summary
This prediction ended on 01.11.22 with a price of €16.86. The prediction closed with a disappointing performance of 11.64%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| GSK plc | 4.030% | 4.030% | 30.104% | 43.750% |
| iShares Core DAX® | -0.479% | -12.062% | -2.045% | 43.868% |
| iShares Nasdaq 100 | -3.377% | -5.130% | 13.432% | 74.088% |
| iShares Nikkei 225® | -0.143% | -12.633% | 23.574% | 44.133% |
| iShares S&P 500 | -2.266% | -5.049% | 8.654% | 56.039% |
According to BiotechBee what are the pros and cons of GSK plc for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by BiotechBee for this prediction
In the thread GlaxoSmithKline plc diskutieren
Sell mit Kursziel 10,0